sk&f-38393 has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farrar, AM | 1 |
| Callahan, JW | 1 |
| Abercrombie, ED | 1 |
| Braun, A | 2 |
| Mouradian, MM | 2 |
| Mohr, E | 1 |
| Fabbrini, G | 2 |
| Chase, TN | 2 |
| Tamminga, CA | 1 |
1 trial available for sk&f-38393 and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Basal Ganglia Diseases; Ben | 1989 |
2 other studies available for sk&f-38393 and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Bicuculline; Cho | 2011 |
Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Benzazepines; Dyskinesia, Drug-Induced; | 1988 |